Navigation Links
Lithium May help in Alzheimer's Disease

Alzheimer's affects about 12 million people worldwide. Lithium may have a potential role in treating Alzheimer's. Lithium targets an enzyme called GSK-3 that facilitates the modification of both the proteins found in Alzheimer's patients. Identification of GSK-3 as a target could help in developing other drugs that disrupt the production of both proteins.

Another advantage to lithium is that it does not disrupt the processing of another protein called notch, as do other potential Alzheimer's drugs. Notch is vital for the production of blood cells.
The drug has been used for decades to treat manic depression. //Alzheimer's is marked by the buildup in the brain of one protein, called amyloid beta, outside nerve cells and a second, called tau, that forms tangles in the cells. Many scientists believe that the accumulation of amyloid beta causes the debilitating effects of the memory-robbing disease.

The recent issue of the journal Nature has reported that in mice experiments, Lithium blocks the production of proteins that form deposits in the brains of Alzheimer's patients. Lithium, though widely used to treat mental problems does have many side effects, including kidney damage.
"Potentially, lithium could be used to reverse both the pathological features of Alzheimer's disease," said Dr. Peter Klein of the University of Pennsylvania who co-authored the current study. "It seems you could block with a single medicine both of the major structural manifestations of the disease. This would be the first time that has been shown," said Dr. Sam Gandy, director of the Farber Institute for Neurosciences at Thomas Jefferson University in Philadelphia.

Klein and his colleagues overproduce a protein that when modified forms amyloid beta in mice. The mouse experiments showed that lithium disrupts that modification process. They also showed that lithium disrupts the modification of tau. Currently it is unclear what role tau plays i n cellsin the progression of Alzheimer's.

Alzheimer's disease usualy starts at the age of 60 years and involves the parts of the brain that control thought, memory, and language. At present we do not know what causes Alzheimer's and there is no cure.
'"/>




Related medicine news :

1. High Doses of Lithium-Like Drugs May Impair Neuronal Function
2. Lithium Increases Gray Matter in Bipolar Brains
3. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
4. Decrease in testosterone levels lead to Alzheimers
5. Smokers are prone to Alzheimers
6. Over-The-Counter Drugs May Prevent Alzheimers
7. Alzheimers followed by head injury
8. Vitamin E useful for Alzheimers
9. Staying mentally energitic prevents Alzheimers
10. Researchers trick Alzheimers Enzyme
11. Drug Offers Hope for Alzheimers disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... , ... June 27, 2016 , ... ... , the only authorized OSHA Training Institute Education Center headquartered in Northern California, ... their workers from extreme heat at their worksites. Employers with workers exposed ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... "FCPX editors ... customizable inside of Final Cut Pro X," said Christina Austin - CEO of Pixel ... style. Final Cut Pro X users can now reveal the media of ...
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... transport experience for the millions of people who require these medical transport services ... industry through the use of technology. Now, SmartEMS has put forth an industry-changing ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: